Literature DB >> 11207045

Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma.

R E Hough1, J R Goepel, H E Alcock, B W Hancock, P C Lorigan, D W Hammond.   

Abstract

The purpose of this study was to identify novel areas of genomic copy number change associated with transformation from follicular lymphoma (FL) to diffuse large B cell lymphoma (DLBL). DNA was extracted from tumour cells micro-dissected from paraffin- embedded tissue sections in 24 patients with FL and subsequent transformation to DLBL and 18 patients with de novo DLBL. Tumour DNA was compared to reference DNA using comparative genomic hybridization. Abnormalities common to all 3 groups were gains on chromosomes 4q, 5q, 7q, 11q and X and losses on 3p, 8p and 10q. Copy number changes seen in both transformed and de novo DLBL and not seen in FL were gains on 2p and losses on 1q, 15q and Xq. Gains on 2q, 6p, 7p and 17q and losses on 5p and 8q were specific to transformed DLBL cases. Gain on 12q12-14 was found in 52% of the transformed DLBL cases and was never seen in its follicular counterpart. Patterns of genomic copy number change associated with specific clinical events in NHL have been demonstrated and suggest that gains on 2q, 6p, 7p, 12q and 17q and losses on 5p and 8q may be important in the transformation from low to high-grade disease. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207045      PMCID: PMC2363775          DOI: 10.1054/bjoc.2000.1638

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  p53 mutations are associated with histologic transformation of follicular lymphoma.

Authors:  F Lo Coco; G Gaidano; D C Louie; K Offit; R S Chaganti; R Dalla-Favera
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

Review 2.  Treatment of non-Hodgkin's lymphoma.

Authors:  J O Armitage
Journal:  N Engl J Med       Date:  1993-04-08       Impact factor: 91.245

3.  Structural abnormalities of the X chromosome in non-Hodgkin's lymphoma.

Authors:  M H Goyns; D W Hammond; C J Harrison; L P Menasce; F M Ross; B W Hancock
Journal:  Leukemia       Date:  1993-06       Impact factor: 11.528

4.  Cytogenetic analysis of a United Kingdom series of non-Hodgkins lymphomas.

Authors:  D W Hammond; J R Goepel; M Aitken; B W Hancock; A M Potter; M H Goyns
Journal:  Cancer Genet Cytogenet       Date:  1992-07-01

5.  Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.

Authors:  J T Lee; D J Innes; M E Williams
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  p53 mutation is associated with progression in follicular lymphomas.

Authors:  C A Sander; T Yano; H M Clark; C Harris; D L Longo; E S Jaffe; M Raffeld
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

7.  Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

Authors:  A Kallioniemi; O P Kallioniemi; D Sudar; D Rutovitz; J W Gray; F Waldman; D Pinkel
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

8.  Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.

Authors:  Z A Khatib; H Matsushime; M Valentine; D N Shapiro; C J Sherr; A T Look
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

9.  Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.

Authors:  G Reifenberger; J Reifenberger; K Ichimura; P S Meltzer; V P Collins
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

10.  Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.

Authors:  K Offit; S C Jhanwar; M Ladanyi; D A Filippa; R S Chaganti
Journal:  Genes Chromosomes Cancer       Date:  1991-05       Impact factor: 5.006

View more
  12 in total

1.  Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.

Authors:  Izidore S Lossos; Ash A Alizadeh; Maximilian Diehn; Roger Warnke; Yvonne Thorstenson; Peter J Oefner; Patrick O Brown; David Botstein; Ronald Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

2.  NFAT1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes.

Authors:  Leonardo K Teixeira; Nina Carrossini; Cristiane Sécca; José E Kroll; Déborah C DaCunha; Douglas V Faget; Lilian D S Carvalho; Sandro J de Souza; João P B Viola
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

Review 3.  Clinical and molecular prognostic factors in follicular lymphoma.

Authors:  Andrew J Davies
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

4.  Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.

Authors:  Andrew J Davies; Andreas Rosenwald; George Wright; Abigail Lee; Kim W Last; Dennis D Weisenburger; Wing C Chan; Jan Delabie; Rita M Braziel; Elias Campo; Randy D Gascoyne; Elaine S Jaffe; Konrad Muller-Hermelink; German Ott; Maria Calaminici; Andrew J Norton; Lindsey K Goff; Jude Fitzgibbon; Louis M Staudt; T Andrew Lister
Journal:  Br J Haematol       Date:  2007-01       Impact factor: 6.998

Review 5.  Chromosome 6p amplification and cancer progression.

Authors:  Gda C Santos; M Zielenska; M Prasad; J A Squire
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

Review 6.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

Review 7.  Molecular cytogenetics in haematological malignancy: current technology and future prospects.

Authors:  Lyndal Kearney; Sharon W Horsley
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

Review 8.  The classification of lymphomas: a new beginning or the end of an era?

Authors:  A S Jack
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

Review 9.  Diffuse large B-cell lymphoma: insights gained from gene expression profiling.

Authors:  Izidore S Lossos; Ronald Levy
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

10.  Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations.

Authors:  Hege Vangstein Aamot; Emina Emilia Torlakovic; Marianne Brodtkorb Eide; Harald Holte; Sverre Heim
Journal:  J Cancer Res Clin Oncol       Date:  2007-01-18       Impact factor: 4.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.